Antibodies targeting PDL1 and methods of using same

JP7791650B2Active Publication Date: 2025-12-24NUMAB INNOVATION AG
-1 Cites 0 Cited by

Patent Information

Application Number
JP2020520150
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-06-29
Filing Date
2018-10-09
Publication Date
2025-12-24
Estimated Expiration
2038-10-09

Smart Images

  • Figure 0007791650000046
    Figure 0007791650000046
  • Figure 0007791650000047
    Figure 0007791650000047
  • Figure 0007791650000048
    Figure 0007791650000048
Patent Text Reader

Abstract

The present invention relates to isolated antibodies that specifically bind to human PDL1, as well as pharmaceutical compositions and methods of use thereof. The present invention further relates to nucleic acids encoding the antibodies, vectors containing the nucleic acids, host cells containing the nucleic acids or the vectors, and methods of producing the antibodies.
Need to check novelty before this filing date? Find Prior Art